Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome

References

• Alexandrova ML, Bochev PG. Oxidative stress during the chronic phase after stroke. Free Radic Biol Med 2005; 39: 297–316
   PubMed Web of Science ®Google Scholar
• Lindsberg PJ, Grau AJ. Inflammation and infections as risk factor for ischemic stroke. Stroke 2003; 34: 2518–2532
   PubMed Web of Science ®Google Scholar
• Paoletti R, Gotto AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation 2004; 109(suppl III)20–26
   Google Scholar
• Lobbes MBI, Lutgens E, Heeneman S, Cleutjens KBJM, Kooi ME, van Engelshoven JMA, Daeman MJAP, Nelemans PJ. Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidised low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 2006; 187: 18–25
   PubMed Web of Science ®Google Scholar
• Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 2003; 74: 312–316
   PubMed Web of Science ®Google Scholar
• Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005; 39: 841–852
   PubMed Web of Science ®Google Scholar
• Ceaser EK, Ramachandran A, Levonen A-L, Darley-Usmar VM. Oxidized low-density lipoprotein and 15-deoxy-Δ12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells. Am J Physiol Heart Circ Physiol 2003; 285: 2298–2308
   Google Scholar
• Sastre J, Pallardo FV, Garcia de la Asuncion J, Vina J. Mitochondria, oxidative stress and aging. Free Radic Res 2000; 32: 189–198
   PubMed Web of Science ®Google Scholar
• Ryglewicz D, Rodo M, Roszczynco M, et al. Dynamics of LDL oxidation in ischemic stroke patients. Acta Neurol Scand 2002; 105: 185–188
   PubMedGoogle Scholar
• Polidori MC. Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med 1998; 25: 561–567
   PubMed Web of Science ®Google Scholar
• ElKossi MMH, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000; 31: 1889–1892
   PubMedGoogle Scholar
• Uno M, Harada M, Takimoto O, et al. Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement. Neurol Res 2005; 27: 94–102
   PubMed Web of Science ®Google Scholar
• Shie F-S, Neely MD, Maezawa I, et al. Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. Am J Pathol 2004; 164: 1173–1181
   PubMedGoogle Scholar
• Faviou E, Vourli G, Nounopoulos C, Zachari A, Dionyssiou-Asteriou A. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease. Free Radic Res 2005; 39: 419–429
   PubMed Web of Science ®Google Scholar
• Uno M, Kitazato KT, Suzue A, Matsuzaki K, Harada M, Itabe H, Nagahiro S. Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction. Free Radic Biol Med 2005; 39: 1109–1116
   PubMed Web of Science ®Google Scholar
• Hulthe J, Fagerberg B. Circulating oxidised LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Arterioscler Thromb Vasc Biol 2002; 22: 1162–1167
   PubMed Web of Science ®Google Scholar
• Masotti L, Ceccarelli E, Forconi S, Cappelli R. Prognostic role of C-reactive protein in very old patients with acute ischemic stroke. J Int Med 2005; 258: 145–152
   PubMed Web of Science ®Google Scholar
• Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham Study. Stroke 2001; 32: 2575–2579
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in multicenter clinical trial. Stroke 1993; 24: 35–41
   PubMed Web of Science ®Google Scholar
• Barber M, Fail M, Shields M, Stott DJ, Langhorne P. Validity and reliability of estimating the Scandinavian Stroke Scale from medical records. Cerebrovasc Dis 2004; 17: 224–227
   PubMed Web of Science ®Google Scholar
• Wade DT, Langton Hewer R. Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 1987; 50: 177–182
   PubMed Web of Science ®Google Scholar
• Holvoet P, Theilmeier G, Shivalkar B, Flameng W, Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998; 18: 415–422
   PubMed Web of Science ®Google Scholar
• Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487–1494
   PubMed Web of Science ®Google Scholar
• The R project for statistical computing. Available at www.r-project.org. Accessed October 2005.
   Google Scholar
• Statistical Analysis System. Available at http://v8doc.sas.com/sashtml/. Accessed October 2005.
   Google Scholar
• Vibo R, Kõrv J, Roose M. The third stroke registry in Tartu, Estonia: Decline of stroke incidence and 28-day case-fatality rate since 1991. Stroke 2005; 36: 2544–2548
   PubMedGoogle Scholar
• Sánchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004; 35: 163–168
   PubMed Web of Science ®Google Scholar
• DiNapoli M, Papa F, Bocola V. Prognostive influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133–138
   PubMedGoogle Scholar
• Drouet L. Fibrinogen—a treatable risk factor?. Cerebrovasc Dis 1996; 6(suppl1)2–6
   Google Scholar
• Weir CJ, Sattar N, Walters MR, Lees KR. Low triglyceride, not low cholesterol concentration independently predicts poor outcome following acute stroke. Cerebrovasc Dis 2003; 16: 76–82
   PubMed Web of Science ®Google Scholar
• Dziedzic T, Slowik A, Gryz EA, Szczudlik A. Lower serum triglyceride level is associated with increased stroke severity. Stroke 2004; 35: e151–e152
   PubMed Web of Science ®Google Scholar